Search
for
Sort by
Research 391–420 of 1000+
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Decreased GATA3 levels cause changed mouse cutaneous innate lymphoid cell fate, facilitating hair follicle recycling
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: An Updated Review for 2023
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Cytokine Engineering Approaches for Regenerative Medicine
- Regulatory T cells in skin regeneration and wound healing
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- New Modalities in the Treatment of Refractory Alopecia Areata
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Engineering strategies to enhance the research progress of mesenchymal stem cells in wound healing
- Adipose Tissue-Derived Therapies for Osteoarthritis: Multifaceted Mechanisms and Clinical Prospects
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Optimization of photobiomodulation therapy for spinal cord injury: A review
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- JAK inhibitors in dermatology: The promise of a new drug class
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Natural killer cells in atopic and autoimmune diseases of the skin
- Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment